ANI PHARMACEUTICALS INC's ticker is and the CUSIP is 00182CAA1. A total of 24 filers reported holding ANI PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $139,000 | -6.7% | 129,000 | 0.0% | 0.00% | – |
| Q2 2019 | $149,000 | +5.7% | 129,000 | 0.0% | 0.00% | – |
| Q1 2019 | $141,000 | +9.3% | 129,000 | 0.0% | 0.00% | – |
| Q4 2018 | $129,000 | -5.8% | 129,000 | 0.0% | 0.00% | – |
| Q3 2018 | $137,000 | +185.4% | 129,000 | +207.1% | 0.00% | – |
| Q4 2016 | $48,000 | +336.4% | 42,000 | +366.7% | 0.00% | – |
| Q3 2016 | $11,000 | +83.3% | 9,000 | +50.0% | 0.00% | – |
| Q2 2016 | $6,000 | +20.0% | 6,000 | 0.0% | 0.00% | – |
| Q1 2016 | $5,000 | – | 6,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wellesley Asset Management | 59,455 | $68,522,000 | 3.54% |
| DLD Asset Management, LP | 4,500,000 | $5,185,000 | 1.70% |
| Worth Venture Partners, LLC | 945,000 | $1,100,000 | 1.18% |
| Perceptive Advisors | 7,500,000 | $8,700,000 | 0.62% |
| WOLVERINE ASSET MANAGEMENT LLC | 15,439,000 | $17,789,000 | 0.23% |
| Allianz Asset Management GmbH | 35,165,000 | $40,795,000 | 0.04% |
| GABELLI FUNDS LLC | 1,500,000 | $1,740,000 | 0.01% |
| AQR Arbitrage LLC | 525,000 | $605,000 | 0.01% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 9,000,000 | $10,328,000 | 0.01% |
| Edge Advisors, LLC | 33,000 | $38,000 | 0.01% |